Nichole Reisdorph
Concepts (660)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 26 | 2025 | 736 | 4.260 |
Why?
| | Mass Spectrometry | 23 | 2025 | 728 | 2.180 |
Why?
| | Metabolome | 12 | 2023 | 391 | 1.950 |
Why?
| | Tandem Mass Spectrometry | 10 | 2023 | 575 | 1.720 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2024 | 641 | 1.310 |
Why?
| | Ion Mobility Spectrometry | 3 | 2020 | 5 | 1.280 |
Why?
| | Asthma | 12 | 2024 | 1805 | 1.220 |
Why?
| | Proteomics | 12 | 2019 | 1203 | 1.200 |
Why?
| | Chromatography, High Pressure Liquid | 11 | 2025 | 593 | 1.110 |
Why?
| | Proteome | 8 | 2019 | 520 | 1.100 |
Why?
| | Ozone | 6 | 2025 | 116 | 1.020 |
Why?
| | Lipids | 6 | 2022 | 723 | 1.010 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 27 | 0.980 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.870 |
Why?
| | Tea | 1 | 2025 | 17 | 0.860 |
Why?
| | Research | 2 | 2018 | 434 | 0.830 |
Why?
| | Chromatography, Liquid | 11 | 2025 | 453 | 0.800 |
Why?
| | Biomarkers | 25 | 2024 | 4351 | 0.800 |
Why?
| | Amino Acids | 4 | 2020 | 519 | 0.790 |
Why?
| | Lung | 14 | 2025 | 4141 | 0.760 |
Why?
| | Eicosanoids | 4 | 2022 | 58 | 0.720 |
Why?
| | Blood Chemical Analysis | 3 | 2014 | 109 | 0.700 |
Why?
| | Metabolic Networks and Pathways | 5 | 2021 | 175 | 0.700 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 7 | 2022 | 928 | 0.690 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.670 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.670 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 1 | 2021 | 29 | 0.650 |
Why?
| | Animals | 60 | 2025 | 38410 | 0.650 |
Why?
| | Mice | 42 | 2025 | 18491 | 0.630 |
Why?
| | Pneumonia | 5 | 2025 | 636 | 0.630 |
Why?
| | Liquid-Liquid Extraction | 3 | 2018 | 13 | 0.630 |
Why?
| | Docosahexaenoic Acids | 5 | 2025 | 90 | 0.610 |
Why?
| | Dietary Supplements | 8 | 2026 | 586 | 0.610 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 14 | 0.610 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2026 | 176 | 0.610 |
Why?
| | Food | 2 | 2020 | 150 | 0.600 |
Why?
| | Breath Tests | 2 | 2017 | 77 | 0.590 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2218 | 0.580 |
Why?
| | Organic Chemicals | 1 | 2020 | 113 | 0.560 |
Why?
| | Phosphopeptides | 1 | 2018 | 19 | 0.560 |
Why?
| | Peptide Mapping | 1 | 2018 | 62 | 0.550 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.550 |
Why?
| | Eicosapentaenoic Acid | 3 | 2024 | 37 | 0.540 |
Why?
| | Monocytes | 1 | 2021 | 539 | 0.530 |
Why?
| | Tyrosine | 1 | 2018 | 218 | 0.520 |
Why?
| | Isotope Labeling | 1 | 2018 | 82 | 0.520 |
Why?
| | Hypersensitivity | 4 | 2022 | 254 | 0.500 |
Why?
| | Tobacco Smoke Pollution | 2 | 2017 | 227 | 0.500 |
Why?
| | Pulmonary Emphysema | 4 | 2019 | 277 | 0.500 |
Why?
| | Smoking | 7 | 2020 | 1483 | 0.490 |
Why?
| | Macrophages | 3 | 2025 | 1529 | 0.490 |
Why?
| | Skin | 3 | 2018 | 759 | 0.490 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 773 | 0.480 |
Why?
| | Humans | 77 | 2026 | 147293 | 0.480 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2018 | 430 | 0.480 |
Why?
| | Plasma | 2 | 2017 | 224 | 0.480 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2020 | 125 | 0.450 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 6041 | 0.450 |
Why?
| | Saliva | 1 | 2017 | 252 | 0.440 |
Why?
| | Glycerophospholipids | 4 | 2022 | 39 | 0.440 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 597 | 0.420 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.420 |
Why?
| | Seafood | 2 | 2025 | 25 | 0.420 |
Why?
| | Computational Biology | 3 | 2020 | 677 | 0.420 |
Why?
| | Peptides | 4 | 2019 | 1003 | 0.420 |
Why?
| | Leukotriene E4 | 3 | 2013 | 24 | 0.410 |
Why?
| | Alveolar Epithelial Cells | 3 | 2019 | 121 | 0.410 |
Why?
| | Mitochondria | 5 | 2023 | 1000 | 0.390 |
Why?
| | Cell Differentiation | 2 | 2021 | 2054 | 0.390 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2013 | 28 | 0.380 |
Why?
| | Microbiota | 4 | 2022 | 736 | 0.380 |
Why?
| | Oxylipins | 4 | 2025 | 47 | 0.380 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 90 | 0.360 |
Why?
| | Cholesterol | 3 | 2024 | 410 | 0.360 |
Why?
| | Niacinamide | 2 | 2026 | 104 | 0.350 |
Why?
| | Endocannabinoids | 2 | 2022 | 56 | 0.350 |
Why?
| | Sirtuin 3 | 3 | 2023 | 60 | 0.350 |
Why?
| | Autoantigens | 4 | 2019 | 429 | 0.340 |
Why?
| | Vitamins | 2 | 2025 | 184 | 0.340 |
Why?
| | Software | 4 | 2020 | 683 | 0.340 |
Why?
| | Male | 45 | 2026 | 73950 | 0.330 |
Why?
| | Liver | 4 | 2020 | 1916 | 0.330 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3448 | 0.320 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2022 | 145 | 0.310 |
Why?
| | Sleep Deprivation | 2 | 2023 | 207 | 0.300 |
Why?
| | Transcriptome | 4 | 2022 | 1059 | 0.290 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 200 | 0.290 |
Why?
| | Species Specificity | 2 | 2020 | 547 | 0.290 |
Why?
| | Analgesia | 1 | 2010 | 106 | 0.280 |
Why?
| | Blood Pressure | 5 | 2026 | 1785 | 0.280 |
Why?
| | Kainic Acid | 2 | 2018 | 33 | 0.260 |
Why?
| | Diet | 4 | 2024 | 1284 | 0.260 |
Why?
| | Minerals | 2 | 2025 | 48 | 0.260 |
Why?
| | Sensitivity and Specificity | 5 | 2017 | 2017 | 0.260 |
Why?
| | Female | 40 | 2026 | 80076 | 0.260 |
Why?
| | Workflow | 2 | 2020 | 183 | 0.250 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2025 | 512 | 0.250 |
Why?
| | Interleukin-13 | 3 | 2024 | 149 | 0.250 |
Why?
| | Cell Line | 8 | 2025 | 2832 | 0.250 |
Why?
| | Urinalysis | 2 | 2020 | 83 | 0.250 |
Why?
| | Chromatography, Ion Exchange | 1 | 2007 | 57 | 0.250 |
Why?
| | Inflammation Mediators | 2 | 2020 | 507 | 0.250 |
Why?
| | Mitochondrial Proteins | 2 | 2019 | 264 | 0.240 |
Why?
| | Pyrrolidines | 2 | 2025 | 126 | 0.240 |
Why?
| | Obesity | 7 | 2024 | 3149 | 0.240 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4604 | 0.240 |
Why?
| | Pilot Projects | 7 | 2026 | 1912 | 0.240 |
Why?
| | Amnesia | 1 | 2026 | 47 | 0.240 |
Why?
| | Ions | 1 | 2026 | 66 | 0.230 |
Why?
| | Mucus | 2 | 2024 | 75 | 0.230 |
Why?
| | Middle Aged | 20 | 2025 | 36821 | 0.230 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 369 | 0.230 |
Why?
| | Receptors, Lipoxin | 1 | 2025 | 6 | 0.230 |
Why?
| | Pulmonary Medicine | 1 | 2006 | 78 | 0.230 |
Why?
| | Dermatitis, Atopic | 3 | 2018 | 322 | 0.230 |
Why?
| | Phenylpropionates | 1 | 2025 | 27 | 0.230 |
Why?
| | Food Analysis | 1 | 2025 | 22 | 0.230 |
Why?
| | Diet, High-Fat | 3 | 2022 | 267 | 0.230 |
Why?
| | Receptors, Formyl Peptide | 1 | 2025 | 17 | 0.230 |
Why?
| | Sodium Nitrite | 2 | 2015 | 39 | 0.220 |
Why?
| | Body Fluids | 2 | 2017 | 71 | 0.220 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.220 |
Why?
| | Laboratories | 1 | 2026 | 111 | 0.220 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2021 | 232 | 0.220 |
Why?
| | Germ-Free Life | 1 | 2025 | 33 | 0.220 |
Why?
| | Fetal Growth Retardation | 2 | 2021 | 594 | 0.220 |
Why?
| | Metals, Heavy | 1 | 2025 | 31 | 0.220 |
Why?
| | Flavoproteins | 1 | 2004 | 8 | 0.210 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2004 | 4 | 0.210 |
Why?
| | Chlamydomonas reinhardtii | 1 | 2004 | 8 | 0.210 |
Why?
| | Membrane Microdomains | 1 | 2024 | 34 | 0.210 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2022 | 97 | 0.210 |
Why?
| | Ethanol | 2 | 2019 | 634 | 0.200 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.200 |
Why?
| | Lectins | 1 | 2024 | 44 | 0.200 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 81 | 0.200 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2016 | 1162 | 0.200 |
Why?
| | Bronchi | 1 | 2025 | 263 | 0.200 |
Why?
| | Mucin 5AC | 1 | 2024 | 71 | 0.200 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2016 | 48 | 0.200 |
Why?
| | Solid Phase Extraction | 2 | 2014 | 28 | 0.200 |
Why?
| | Feces | 2 | 2025 | 500 | 0.200 |
Why?
| | Benzodioxoles | 1 | 2025 | 162 | 0.200 |
Why?
| | Eye Proteins | 1 | 2004 | 93 | 0.200 |
Why?
| | Pyridines | 2 | 2025 | 610 | 0.200 |
Why?
| | Oxadiazoles | 1 | 2003 | 37 | 0.200 |
Why?
| | Proteins | 3 | 2017 | 1024 | 0.200 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2020 | 143 | 0.200 |
Why?
| | Mice, Knockout | 10 | 2025 | 3153 | 0.200 |
Why?
| | Sleep | 4 | 2023 | 895 | 0.200 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2003 | 56 | 0.190 |
Why?
| | Isoxazoles | 1 | 2003 | 56 | 0.190 |
Why?
| | Rhinovirus | 1 | 2003 | 60 | 0.190 |
Why?
| | Quinolones | 1 | 2025 | 206 | 0.190 |
Why?
| | Epithelial Cells | 3 | 2025 | 1141 | 0.190 |
Why?
| | Capsid | 1 | 2003 | 94 | 0.190 |
Why?
| | Aminophenols | 1 | 2025 | 204 | 0.190 |
Why?
| | Plant Extracts | 1 | 2025 | 191 | 0.190 |
Why?
| | NAD | 2 | 2026 | 79 | 0.190 |
Why?
| | Arachidonic Acids | 1 | 2022 | 42 | 0.180 |
Why?
| | Acylation | 2 | 2019 | 30 | 0.180 |
Why?
| | Prostaglandins | 2 | 2022 | 94 | 0.180 |
Why?
| | Cells, Cultured | 6 | 2021 | 4169 | 0.180 |
Why?
| | Drosophila Proteins | 1 | 2004 | 215 | 0.180 |
Why?
| | Lipoxins | 1 | 2021 | 10 | 0.180 |
Why?
| | Acute Lung Injury | 1 | 2025 | 312 | 0.180 |
Why?
| | Linear Models | 2 | 2018 | 852 | 0.180 |
Why?
| | Myocardium | 3 | 2019 | 947 | 0.180 |
Why?
| | Oxidative Stress | 4 | 2021 | 1368 | 0.170 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2020 | 37 | 0.170 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 57 | 0.170 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2025 | 374 | 0.170 |
Why?
| | Bacterial Toxins | 1 | 2022 | 109 | 0.170 |
Why?
| | Indoles | 1 | 2025 | 510 | 0.170 |
Why?
| | Pyrazoles | 1 | 2025 | 518 | 0.170 |
Why?
| | Dinoprostone | 1 | 2022 | 180 | 0.170 |
Why?
| | Hippocampus | 2 | 2018 | 989 | 0.170 |
Why?
| | Orthomyxoviridae Infections | 2 | 2024 | 72 | 0.170 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2019 | 98 | 0.170 |
Why?
| | Brain Chemistry | 1 | 2021 | 121 | 0.170 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 393 | 0.170 |
Why?
| | Calcifediol | 2 | 2022 | 31 | 0.170 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 389 | 0.170 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 25 | 0.170 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 162 | 0.170 |
Why?
| | Receptors, Scavenger | 1 | 2021 | 22 | 0.170 |
Why?
| | Amidohydrolases | 1 | 2021 | 31 | 0.170 |
Why?
| | Sepsis | 1 | 2007 | 671 | 0.160 |
Why?
| | Macrophages, Alveolar | 1 | 2024 | 377 | 0.160 |
Why?
| | Neuroprotection | 1 | 2021 | 46 | 0.160 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2021 | 54 | 0.160 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 32 | 0.160 |
Why?
| | Vitamin D Deficiency | 1 | 2022 | 190 | 0.160 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.160 |
Why?
| | Leukocytes, Mononuclear | 4 | 2022 | 590 | 0.160 |
Why?
| | Lipid Metabolism | 3 | 2018 | 538 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 59 | 0.160 |
Why?
| | Phosphorylation | 4 | 2019 | 1721 | 0.150 |
Why?
| | Vital Capacity | 2 | 2018 | 293 | 0.150 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 85 | 0.150 |
Why?
| | Melatonin | 1 | 2021 | 164 | 0.150 |
Why?
| | Cognitive Dysfunction | 1 | 2026 | 479 | 0.150 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 131 | 0.150 |
Why?
| | Biotransformation | 1 | 2020 | 62 | 0.150 |
Why?
| | Succinic Acid | 1 | 2019 | 46 | 0.150 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 129 | 0.150 |
Why?
| | Aged | 12 | 2026 | 26514 | 0.150 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2019 | 15 | 0.150 |
Why?
| | Umbilical Arteries | 1 | 2020 | 52 | 0.150 |
Why?
| | Neuroprotective Agents | 1 | 2021 | 149 | 0.150 |
Why?
| | Myofibrils | 1 | 2019 | 53 | 0.150 |
Why?
| | Tubulin | 1 | 2020 | 146 | 0.150 |
Why?
| | Cross-Over Studies | 2 | 2020 | 617 | 0.150 |
Why?
| | Hyperinsulinism | 1 | 2020 | 115 | 0.150 |
Why?
| | Epithelium | 1 | 2020 | 311 | 0.150 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.150 |
Why?
| | Uterine Artery | 1 | 2020 | 74 | 0.150 |
Why?
| | Bacteria | 1 | 2025 | 769 | 0.140 |
Why?
| | Fluorenes | 1 | 2019 | 45 | 0.140 |
Why?
| | Islets of Langerhans | 2 | 2019 | 853 | 0.140 |
Why?
| | Inhalation Exposure | 2 | 2021 | 103 | 0.140 |
Why?
| | Insulin | 3 | 2022 | 2526 | 0.140 |
Why?
| | DNA End-Joining Repair | 1 | 2019 | 22 | 0.140 |
Why?
| | Lung Injury | 1 | 2022 | 262 | 0.140 |
Why?
| | Bariatric Surgery | 1 | 2022 | 258 | 0.140 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 144 | 0.140 |
Why?
| | Rhinitis | 1 | 2020 | 169 | 0.140 |
Why?
| | Dietary Proteins | 1 | 2020 | 135 | 0.140 |
Why?
| | Aging | 3 | 2023 | 1992 | 0.140 |
Why?
| | Liposomes | 1 | 2020 | 268 | 0.140 |
Why?
| | Microtubules | 1 | 2020 | 267 | 0.140 |
Why?
| | Trypsin | 1 | 2018 | 75 | 0.140 |
Why?
| | Gene Expression | 4 | 2020 | 1481 | 0.140 |
Why?
| | Spleen | 1 | 2020 | 509 | 0.140 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2018 | 42 | 0.140 |
Why?
| | Synapses | 1 | 2022 | 448 | 0.140 |
Why?
| | Leukotrienes | 1 | 2018 | 28 | 0.140 |
Why?
| | B-Lymphocyte Subsets | 1 | 2018 | 76 | 0.140 |
Why?
| | C-Peptide | 2 | 2016 | 191 | 0.140 |
Why?
| | Cysteine | 1 | 2019 | 211 | 0.130 |
Why?
| | Sinusitis | 1 | 2020 | 230 | 0.130 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2018 | 39 | 0.130 |
Why?
| | Limit of Detection | 1 | 2018 | 92 | 0.130 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 287 | 0.130 |
Why?
| | Diet, Ketogenic | 1 | 2018 | 39 | 0.130 |
Why?
| | Adult | 15 | 2025 | 41405 | 0.130 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 6 | 0.130 |
Why?
| | Fatty Acids, Essential | 1 | 2017 | 2 | 0.130 |
Why?
| | Inflammasomes | 1 | 2018 | 145 | 0.130 |
Why?
| | Kynurenine | 1 | 2018 | 114 | 0.130 |
Why?
| | Hydrolases | 1 | 2017 | 41 | 0.130 |
Why?
| | Adiponectin | 2 | 2022 | 244 | 0.130 |
Why?
| | Sample Size | 1 | 2017 | 124 | 0.120 |
Why?
| | Health | 1 | 2017 | 82 | 0.120 |
Why?
| | Interleukin-6 | 2 | 2021 | 784 | 0.120 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 367 | 0.120 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 79 | 0.120 |
Why?
| | Immunophenotyping | 2 | 2018 | 325 | 0.120 |
Why?
| | Disease | 1 | 2017 | 96 | 0.120 |
Why?
| | Proline | 1 | 2017 | 82 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 634 | 0.120 |
Why?
| | Antibodies | 1 | 2018 | 398 | 0.120 |
Why?
| | Sphingolipids | 1 | 2017 | 83 | 0.120 |
Why?
| | Autoimmunity | 2 | 2021 | 935 | 0.120 |
Why?
| | Artifacts | 1 | 2017 | 144 | 0.120 |
Why?
| | Hyperglycemia | 1 | 2020 | 381 | 0.120 |
Why?
| | Actins | 1 | 2018 | 428 | 0.120 |
Why?
| | Immunity, Humoral | 1 | 2017 | 119 | 0.120 |
Why?
| | Epitopes | 2 | 2016 | 475 | 0.120 |
Why?
| | Emphysema | 2 | 2013 | 100 | 0.120 |
Why?
| | Cardiomyopathies | 1 | 2019 | 339 | 0.120 |
Why?
| | Apoptosis | 4 | 2017 | 2454 | 0.110 |
Why?
| | Acetylation | 3 | 2023 | 262 | 0.110 |
Why?
| | HEK293 Cells | 1 | 2018 | 745 | 0.110 |
Why?
| | Vascular Stiffness | 2 | 2018 | 488 | 0.110 |
Why?
| | Sex Characteristics | 1 | 2021 | 799 | 0.110 |
Why?
| | Cytokines | 4 | 2025 | 2086 | 0.110 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 178 | 0.110 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2011 | 110 | 0.110 |
Why?
| | Arginine | 1 | 2017 | 265 | 0.110 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2016 | 174 | 0.110 |
Why?
| | Signal Transduction | 4 | 2022 | 5272 | 0.110 |
Why?
| | Amino Acid Sequence | 5 | 2016 | 2134 | 0.110 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 32 | 0.110 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.110 |
Why?
| | Electrophysiology | 1 | 2015 | 219 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2017 | 269 | 0.110 |
Why?
| | Respiratory Mucosa | 2 | 2024 | 324 | 0.110 |
Why?
| | Chlorine | 1 | 2015 | 59 | 0.110 |
Why?
| | Forensic Sciences | 1 | 2014 | 4 | 0.110 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 365 | 0.110 |
Why?
| | Aorta | 2 | 2015 | 443 | 0.110 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 289 | 0.100 |
Why?
| | Brain | 2 | 2018 | 3009 | 0.100 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 199 | 0.100 |
Why?
| | Carotid Arteries | 1 | 2015 | 208 | 0.100 |
Why?
| | Aged, 80 and over | 4 | 2026 | 8430 | 0.100 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 88 | 0.100 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2022 | 1253 | 0.100 |
Why?
| | Lipopolysaccharides | 2 | 2025 | 863 | 0.100 |
Why?
| | Leukotriene Antagonists | 1 | 2013 | 24 | 0.100 |
Why?
| | Gangliosides | 1 | 2013 | 23 | 0.100 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 10 | 0.100 |
Why?
| | Up-Regulation | 2 | 2019 | 848 | 0.100 |
Why?
| | Education | 1 | 2013 | 106 | 0.100 |
Why?
| | Adrenergic beta-Agonists | 1 | 2013 | 92 | 0.100 |
Why?
| | Methyl Ethers | 1 | 2013 | 19 | 0.100 |
Why?
| | Lung Diseases | 2 | 2013 | 787 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 441 | 0.100 |
Why?
| | Methanol | 1 | 2013 | 44 | 0.090 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2019 | 3952 | 0.090 |
Why?
| | Health Status | 1 | 2018 | 839 | 0.090 |
Why?
| | Pyridinium Compounds | 2 | 2026 | 31 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2018 | 3660 | 0.090 |
Why?
| | Bronchodilator Agents | 1 | 2013 | 187 | 0.090 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 194 | 0.090 |
Why?
| | Nasal Mucosa | 2 | 2024 | 113 | 0.090 |
Why?
| | Hydroxyeicosatetraenoic Acids | 2 | 2022 | 35 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1183 | 0.090 |
Why?
| | Mice, Inbred NOD | 4 | 2016 | 616 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2019 | 858 | 0.090 |
Why?
| | Heart Diseases | 1 | 2015 | 341 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2017 | 878 | 0.090 |
Why?
| | Double-Blind Method | 3 | 2026 | 2080 | 0.090 |
Why?
| | Epilepsy | 1 | 2016 | 399 | 0.080 |
Why?
| | Molecular Sequence Data | 4 | 2016 | 2886 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 1077 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2021 | 1798 | 0.080 |
Why?
| | Calcium | 1 | 2017 | 1197 | 0.080 |
Why?
| | fas Receptor | 1 | 2011 | 91 | 0.080 |
Why?
| | Kaposi Varicelliform Eruption | 1 | 2011 | 21 | 0.080 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 348 | 0.080 |
Why?
| | Ovarian Follicle | 1 | 2011 | 78 | 0.080 |
Why?
| | Fatty Acids | 3 | 2018 | 461 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2018 | 332 | 0.080 |
Why?
| | Motor Activity | 1 | 2015 | 719 | 0.080 |
Why?
| | Anti-Asthmatic Agents | 1 | 2013 | 264 | 0.080 |
Why?
| | Pregnancy | 5 | 2025 | 7274 | 0.080 |
Why?
| | Aluminum | 1 | 2010 | 43 | 0.080 |
Why?
| | Mice, Obese | 2 | 2021 | 68 | 0.080 |
Why?
| | Rats | 4 | 2022 | 5613 | 0.080 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2010 | 56 | 0.080 |
Why?
| | Dietary Fats | 2 | 2022 | 309 | 0.080 |
Why?
| | Sarcomeres | 1 | 2010 | 101 | 0.080 |
Why?
| | E2F2 Transcription Factor | 1 | 2009 | 14 | 0.080 |
Why?
| | Light | 2 | 2021 | 403 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 125 | 0.080 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2009 | 25 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2625 | 0.080 |
Why?
| | Chromogranin A | 1 | 2010 | 43 | 0.080 |
Why?
| | Ovary | 1 | 2011 | 236 | 0.070 |
Why?
| | Lymphocyte Activation | 3 | 2018 | 1140 | 0.070 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2009 | 79 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2010 | 245 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2015 | 959 | 0.070 |
Why?
| | Protein C | 1 | 2009 | 54 | 0.070 |
Why?
| | Binding Sites | 2 | 2020 | 1319 | 0.070 |
Why?
| | Glycoproteins | 1 | 2010 | 358 | 0.070 |
Why?
| | Sphingomyelins | 2 | 2020 | 22 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2010 | 337 | 0.070 |
Why?
| | Muscle Proteins | 1 | 2010 | 244 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 2 | 2019 | 46 | 0.070 |
Why?
| | Sirtuins | 2 | 2019 | 50 | 0.070 |
Why?
| | Vasoconstriction | 1 | 2009 | 216 | 0.070 |
Why?
| | Reactive Oxygen Species | 2 | 2023 | 616 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2021 | 394 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2627 | 0.070 |
Why?
| | Glucose | 2 | 2023 | 1051 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2009 | 372 | 0.060 |
Why?
| | Diet, Western | 2 | 2018 | 88 | 0.060 |
Why?
| | Inflammation | 3 | 2024 | 2920 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2542 | 0.060 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 395 | 0.060 |
Why?
| | Child | 6 | 2024 | 22979 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2223 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2019 | 347 | 0.060 |
Why?
| | Cognition | 1 | 2015 | 1286 | 0.060 |
Why?
| | Biomedical Research | 1 | 2013 | 723 | 0.060 |
Why?
| | Phenotype | 4 | 2018 | 3216 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2013 | 932 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2008 | 364 | 0.060 |
Why?
| | Curriculum | 1 | 2013 | 1082 | 0.060 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 389 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2011 | 395 | 0.060 |
Why?
| | Exercise | 1 | 2018 | 2219 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2334 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2010 | 698 | 0.060 |
Why?
| | Animal Feed | 1 | 2025 | 50 | 0.060 |
Why?
| | Fibroblasts | 1 | 2011 | 1039 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 33 | 0.050 |
Why?
| | Iodine | 1 | 2025 | 27 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1266 | 0.050 |
Why?
| | Algal Proteins | 1 | 2004 | 4 | 0.050 |
Why?
| | Drug Combinations | 1 | 2025 | 399 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 65 | 0.050 |
Why?
| | Choline | 1 | 2025 | 138 | 0.050 |
Why?
| | Gene Deletion | 1 | 2025 | 392 | 0.050 |
Why?
| | Cryptochromes | 1 | 2004 | 25 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 80 | 0.050 |
Why?
| | Antigen-Antibody Reactions | 1 | 2003 | 49 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 264 | 0.050 |
Why?
| | Down-Regulation | 2 | 2020 | 618 | 0.050 |
Why?
| | Oxazoles | 1 | 2003 | 48 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2249 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 2026 | 293 | 0.050 |
Why?
| | Protoplasts | 1 | 2003 | 6 | 0.050 |
Why?
| | Quality Control | 1 | 2023 | 161 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 643 | 0.050 |
Why?
| | Enzyme Activation | 2 | 2019 | 762 | 0.050 |
Why?
| | Introns | 1 | 2004 | 260 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2004 | 156 | 0.050 |
Why?
| | Polyunsaturated Alkamides | 1 | 2022 | 7 | 0.050 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2022 | 9 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2003 | 417 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2023 | 202 | 0.050 |
Why?
| | Receptors, Cannabinoid | 1 | 2022 | 13 | 0.050 |
Why?
| | Virus Assembly | 1 | 2003 | 82 | 0.050 |
Why?
| | Exons | 1 | 2004 | 365 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1371 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 25 | 0.050 |
Why?
| | Seeds | 1 | 2003 | 70 | 0.050 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2022 | 39 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 48 | 0.050 |
Why?
| | Young Adult | 5 | 2020 | 14437 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 398 | 0.050 |
Why?
| | Mutation | 2 | 2004 | 4130 | 0.050 |
Why?
| | Cholecalciferol | 1 | 2022 | 61 | 0.050 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2022 | 38 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3565 | 0.040 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2022 | 131 | 0.040 |
Why?
| | HeLa Cells | 1 | 2003 | 633 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2022 | 147 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2008 | 1171 | 0.040 |
Why?
| | Immunity | 1 | 2022 | 141 | 0.040 |
Why?
| | Cattle | 1 | 2024 | 948 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2024 | 615 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2026 | 1145 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 18 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2020 | 36 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 249 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 59 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 62 | 0.040 |
Why?
| | Adolescent | 4 | 2020 | 22825 | 0.040 |
Why?
| | Adenosine | 1 | 2022 | 255 | 0.040 |
Why?
| | Prescriptions | 1 | 2021 | 75 | 0.040 |
Why?
| | Sirtuin 2 | 1 | 2020 | 28 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 212 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2022 | 256 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 79 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 119 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2020 | 48 | 0.040 |
Why?
| | Metaplasia | 1 | 2020 | 57 | 0.040 |
Why?
| | Placental Insufficiency | 1 | 2021 | 126 | 0.040 |
Why?
| | Neurons | 2 | 2023 | 1672 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 212 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2020 | 43 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2022 | 3027 | 0.040 |
Why?
| | Sex Factors | 2 | 2018 | 2136 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2022 | 293 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2021 | 269 | 0.040 |
Why?
| | Calcium Signaling | 2 | 2015 | 246 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 145 | 0.040 |
Why?
| | Triglycerides | 1 | 2022 | 529 | 0.040 |
Why?
| | Nutritional Sciences | 1 | 2020 | 35 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2020 | 57 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 539 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 104 | 0.040 |
Why?
| | Water | 1 | 2003 | 452 | 0.040 |
Why?
| | Neutrophils | 1 | 2025 | 1135 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 6099 | 0.040 |
Why?
| | Cellular Reprogramming | 1 | 2020 | 98 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 119 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 121 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 224 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 126 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 335 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2458 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 487 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2003 | 687 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 405 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 242 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 118 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 425 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 186 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2020 | 142 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 879 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 313 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2003 | 567 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 58 | 0.040 |
Why?
| | Cilia | 1 | 2020 | 173 | 0.040 |
Why?
| | Fibrinogen | 2 | 2010 | 180 | 0.040 |
Why?
| | Metagenomics | 1 | 2020 | 151 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2018 | 165 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 268 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 167 | 0.030 |
Why?
| | Germinal Center | 1 | 2018 | 64 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 95 | 0.030 |
Why?
| | Models, Molecular | 1 | 2003 | 1606 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 145 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2021 | 914 | 0.030 |
Why?
| | Native Polyacrylamide Gel Electrophoresis | 1 | 2018 | 3 | 0.030 |
Why?
| | Microglia | 1 | 2021 | 286 | 0.030 |
Why?
| | Naphthoquinones | 1 | 2018 | 20 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2019 | 365 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 295 | 0.030 |
Why?
| | Methionine | 1 | 2018 | 161 | 0.030 |
Why?
| | Phospholipase A2 Inhibitors | 1 | 2017 | 3 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2018 | 149 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2133 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1344 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 167 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2018 | 325 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1550 | 0.030 |
Why?
| | Nutritional Status | 1 | 2020 | 353 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 305 | 0.030 |
Why?
| | Energy Intake | 1 | 2020 | 514 | 0.030 |
Why?
| | Forensic Medicine | 1 | 2017 | 19 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 930 | 0.030 |
Why?
| | Fetus | 1 | 2021 | 805 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1776 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 37 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2017 | 2812 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2018 | 234 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 334 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 867 | 0.030 |
Why?
| | Circadian Rhythm | 1 | 2021 | 514 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2018 | 133 | 0.030 |
Why?
| | RNA-Binding Proteins | 2 | 2011 | 451 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 506 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 836 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 997 | 0.030 |
Why?
| | Influenza A virus | 1 | 2017 | 119 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 427 | 0.030 |
Why?
| | Family | 1 | 2021 | 690 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1224 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 567 | 0.030 |
Why?
| | Methemoglobin | 1 | 2015 | 24 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 267 | 0.030 |
Why?
| | DNA Damage | 1 | 2019 | 440 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 318 | 0.030 |
Why?
| | Body Mass Index | 2 | 2015 | 2470 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2017 | 338 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 263 | 0.030 |
Why?
| | Cystic Fibrosis | 1 | 2025 | 1171 | 0.030 |
Why?
| | Etiocholanolone | 1 | 2015 | 5 | 0.030 |
Why?
| | Ranolazine | 1 | 2015 | 23 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Gerbillinae | 1 | 2015 | 73 | 0.030 |
Why?
| | Thiocyanates | 1 | 2015 | 28 | 0.030 |
Why?
| | Elasticity | 1 | 2015 | 189 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2973 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 793 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2015 | 268 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 94 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2021 | 1496 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 839 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1844 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 209 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 8164 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 840 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 107 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 444 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 366 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2954 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 12016 | 0.030 |
Why?
| | Salmeterol Xinafoate | 1 | 2013 | 20 | 0.030 |
Why?
| | Fluticasone | 1 | 2013 | 53 | 0.020 |
Why?
| | Cyclopropanes | 1 | 2013 | 84 | 0.020 |
Why?
| | Time Factors | 2 | 2019 | 7173 | 0.020 |
Why?
| | Pregnenolone | 1 | 2013 | 3 | 0.020 |
Why?
| | Androstadienes | 1 | 2013 | 77 | 0.020 |
Why?
| | Immune Tolerance | 1 | 2016 | 386 | 0.020 |
Why?
| | Albuterol | 1 | 2013 | 76 | 0.020 |
Why?
| | Acetates | 1 | 2013 | 78 | 0.020 |
Why?
| | Disease Progression | 1 | 2021 | 2890 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2030 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2013 | 319 | 0.020 |
Why?
| | Sulfides | 1 | 2013 | 92 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 430 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 337 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 500 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4591 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2013 | 207 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 522 | 0.020 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 451 | 0.020 |
Why?
| | Quinolines | 1 | 2013 | 192 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 936 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2013 | 440 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 374 | 0.020 |
Why?
| | Mesocricetus | 1 | 2011 | 52 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 61 | 0.020 |
Why?
| | Antioxidants | 1 | 2015 | 550 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 138 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 305 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1940 | 0.020 |
Why?
| | Eosinophils | 1 | 2013 | 319 | 0.020 |
Why?
| | Regression Analysis | 1 | 2013 | 1003 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2026 | 11947 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 161 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 849 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2015 | 892 | 0.020 |
Why?
| | Salts | 1 | 2010 | 35 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 487 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2015 | 547 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 81 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 52 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 84 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 572 | 0.020 |
Why?
| | Surgical Tape | 1 | 2009 | 5 | 0.020 |
Why?
| | Endothelin-Converting Enzymes | 1 | 2009 | 10 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2009 | 32 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2013 | 786 | 0.020 |
Why?
| | Metalloendopeptidases | 1 | 2009 | 63 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 219 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 174 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 30 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 303 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 6011 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 71 | 0.020 |
Why?
| | Risk | 1 | 2011 | 927 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 119 | 0.020 |
Why?
| | Phosphotyrosine | 1 | 2008 | 38 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 104 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 181 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6543 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 405 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 93 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1504 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 174 | 0.020 |
Why?
| | Nanotechnology | 1 | 2008 | 114 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 239 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 943 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2011 | 458 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 600 | 0.010 |
Why?
| | Lymphoma | 1 | 2008 | 253 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 915 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 440 | 0.010 |
Why?
| | Age Factors | 1 | 2013 | 3372 | 0.010 |
Why?
| | Cell Membrane | 1 | 2009 | 711 | 0.010 |
Why?
| | Algorithms | 1 | 2013 | 1868 | 0.010 |
Why?
| | Histones | 1 | 2010 | 672 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2009 | 901 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1253 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 532 | 0.010 |
Why?
| | United States | 1 | 2022 | 16313 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1794 | 0.010 |
Why?
| | Raffinose | 1 | 2003 | 29 | 0.010 |
Why?
| | Germination | 1 | 2003 | 8 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2791 | 0.010 |
Why?
| | Sucrose | 1 | 2003 | 114 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 2017 | 0.010 |
Why?
| | Vaccination | 1 | 2010 | 1443 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1514 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 11017 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 6164 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|